Nobuhisa Ishikawa
Nobuhisa Ishikawa publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease (COPD) Research.
- World rank
- #677,930 of 7,710,434 ranked researchers
- Rank in Japan
- #7,790 of 383,136
- Works
- 283
- Citations
- 7.1k
- Citations per work
- 25.2
What does Nobuhisa Ishikawa research?
Nobuhisa Ishikawa's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences16859.4%
- Medicine16859.4%
- Everything else7426.2%
- Life Sciences4114.4%
- 1Pulmonary and Respiratory Medicine37% of their works
- 2Oncology15% of their works
- 3Molecular Biology11% of their works
- 4Physiology4% of their works
- 5Immunology4% of their works
- 6Cardiology and Cardiovascular Medicine3% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Lung Cancer Research Studies
- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Glycosylation and Glycoproteins Research
- Sarcoidosis and Beryllium Toxicity Research
Which keywords describe Nobuhisa Ishikawa's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Fibrosis, Idiopathic Pulmonary Fibrosis, Chemotherapy and Diagnosis.
- Cardiac
- Glycans
- Immune Checkpoint Blockade
- Lung Cancer
- CT Screening
- COPD
- Diagnosis
- Idiopathic Pulmonary Fibrosis
- EGFR Mutations
- Targeted Therapy
- Clinical Trials
- ALK Inhibitors
- Fibrosis
- Chemotherapy
- Management
- spirometry
- Genomic Profiles
- Small-Cell Lung Cancer
- PD-1 and PD-L1
- Glycosylation
- Sarcoidosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Clinical Trials862 topics
- Targeted Therapy862 topics
- ALK Inhibitors601 topic
- EGFR Mutations601 topic
- Fibrosis551 topic
- Idiopathic Pulmonary Fibrosis551 topic
- Chemotherapy522 topics
- Diagnosis392 topics
- Management392 topics
- COPD271 topic
- spirometry271 topic
- CT Screening261 topic
- Genomic Profiles261 topic
- Lung Cancer261 topic
- Small-Cell Lung Cancer261 topic
- Immune Checkpoint Blockade201 topic
- PD-1 and PD-L1201 topic
- Glycans161 topic
- Glycosylation161 topic
- Cardiac121 topic
- Sarcoidosis121 topic
Where does Nobuhisa Ishikawa work?
Nobuhisa Ishikawa's main affiliation in the publication record is Hiroshima University, Japan.
How many publications and citations does Nobuhisa Ishikawa have?
OpenAlex counts 283 works and 7,119 citations for Nobuhisa Ishikawa, an h-index of 43, ranking #677,930 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nobuhisa Ishikawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.